Efficacy of Tocilizumab in COVID-19: Single-Center Experience

BACKGROUND: Cytokine release syndrome can be observed during the course of COVID-19. Tocilizumab is used for treating this highly fatal syndrome. We think that the starting time of tocilizumab is important. In this article, we aimed to discuss the efficacy of tocilizumab and to review the necessity...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaya, Safak, Kavak, Seyhmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717045/
https://www.ncbi.nlm.nih.gov/pubmed/34977235
http://dx.doi.org/10.1155/2021/1934685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717045/
https://www.ncbi.nlm.nih.gov/pubmed/34977235
http://dx.doi.org/10.1155/2021/1934685

Ejemplares similares